MVP Announces FY25 Full Year Results
Filed with ASX · · 3 pages · English
Watch Medical Developments International's latest callMedical Developments International (ASX:MVP) Q4 2026 Earnings Call · Replay · Aug 19Read the transcript of Medical Developments International (ASX:MVP) Q4 2026 Earnings CallMedical Developments International Limited on 6ix
In the deck
Story so far
Earlier from Medical Developments International
- FY25 Full Year Results Investor Presentation
- Appendix 4C and Quarterly Activity Report - 30 June 2025
- Appendix 4C and Quarterly Activity Report - 31 March 2025
- FY25 Half Year Report (including Appendix 4D)
- FY25 Half Year Presentation
Later from Medical Developments International
- FY25 Full Year Results
- Appendix 4C and Quarterly Activity Report 30 September2025
- Vaxxas Appoints Veteran Vaccine Leader to Board as Company Advances Needle-Free Vaccine Patch Towards Market
- Vaxxas Appoints Former Merck Global Vaccines President David Peacock as CEO
- Appendix 4C and Quarterly Activity Report 31 December 2025
Follow Medical Developments International into a list and get an email when it puts out news.
Follow Medical Developments International